which glp 1 drugs are approved for obesity Indications GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Medications Infographic | Medidex

A crucial area of our practice involves therapies based on GLP-1 (glucagon-like peptide-1), a naturally occurring hormone produced in the intestines

These combined effects make GLP-1 therapy a comprehensive tool for anyone looking to reduce the health risks associated with obesity and improve their long-term quality of life

The SURMOUNT-1 trial specifically noted that participants with a BMI of 35 or higher who received the 15mg tirzepatide dose lost an average of 26.5% of their body weight, substantially higher than the overall trial average

One large study found that semaglutide use was associated with improved joint outcomes, raising the possibility of a disease-modifying effect

For offices and small businesses, its also a simple way to invest in employee well-being with something everyone can appreciate